-
LTRA's
Montelukast (Singulair)
-
Indication
- Only LTRA approved for allergic rhinitis
- Allergic rhinitis, similar effectiveness to second generation antihistamines, less than INGC
-
MoA
Anti-inflammatory, competitive antagonist of Cys-LT1
-
SEs
Eosinophilia, vasculitis (Churg-Strauss)
-
|
|